Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Qingre soft capsule is a Traditional Chinese Medicine (TCM) formulation developed and marketed by Dalian Aosen Pharmaceutical through its subsidiary, Dalian Mingsen Pharmaceutical. It is an orally administered finished formulation indicated for the treatment of symptoms associated with the common cold and influenza, including headache, fever, chills, body aches, runny nose, cough, and sore throat. The product is a complex herbal mixture typically containing ingredients such as Schizonepeta spike, mint, bupleurum root, and perilla leaf. As a TCM product, it is designed to harmonize the body and relieve "wind-cold" symptoms, functioning as a multi-component therapy rather than targeting a single biological pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ganmao Qingre soft capsule.